S235: A TWO-PART, SINGLE- AND TWO-ARM RANDOMIZED, OPEN-LABEL STUDY TO EVALUATE THE SAFETY, TOLERABILITY AND PHARMACOKINETICS OF THE S1P RECEPTOR MODULATOR KRP203 IN SUBJECTS WITH H... by S. dertschnig, J. finke, D. heim, U. schanz, E. holler, U. holtick, G. socié, T. teshima, C. bucher, J. passweg

Get full text

DYSLIPIDEMIA AFTER INTENSIVE IMMUNOSUPPRESSIVE THERAPY VERSUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN APLASTIC ANEMIA: A SINGLE-CENTER EXPERIENCE by C Holeczek, J Halter, C Arranto, S Schaedelin, R Mathew, A Leuppi-Taegtmeyer, T Burkard, M Betz, J Passweg, B Drexler

Get full text

P1456: EARLY SAFETY AND CLINICAL COURSE OF PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MEASURABLE RESIDUAL DISEASE RECEIVING GTA002, AN OFF-THE-SHELF, EX VIVO-CULTURED ALLOGENEIC NK C... by M. Heuser, W. Fiedler, A. Block, D. C. de Leeuw, A. van de Loosdrecht, A. Astrid Tschan-Plessl, J. Passweg, A. Kloos, A. Schwarzer, L. Venturini, A. D. Duru, K. Pinkernell, A. Ganser

Get full text

S238: MATCHED RELATED VERSUS UNRELATED VERSUS HAPLOIDENTICAL DONORS FOR ALLOGENEIC TRANSPLANTATION IN AML PATIENTS ACHIEVING FIRST COMPLETE REMISSION AFTER TWO INDUCTION COURSES: A... by A. Nagler, M. Labopin, S. Mielke, J. Passweg, D. Blaise, T. Gedde-Dahl, J. J. Cornelissen, U. Salmenniemi, I. Yakoub-Agha, P. Reményi, G. Socié, G. Van Gorkom, H. Labussière-Wallet, X.-J. Huang, M. Thérèse Rubio, J. L Byrne, C. Craddock, L. Griskevicius, F. Ciceri, M. Mohty

Get full text